These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30655572)

  • 1. Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures.
    Nakashima M; Tohyama J; Nakagawa E; Watanabe Y; Siew CG; Kwong CS; Yamoto K; Hiraide T; Fukuda T; Kaname T; Nakabayashi K; Hata K; Ogata T; Saitsu H; Matsumoto N
    J Hum Genet; 2019 Apr; 64(4):313-322. PubMed ID: 30655572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsy.
    Poirier K; Hubert L; Viot G; Rio M; Billuart P; Besmond C; Bienvenu T
    Hum Mutat; 2017 Aug; 38(8):932-941. PubMed ID: 28585349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poirier-Bienvenu neurodevelopmental syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growth.
    Selvam P; Jain A; Cheema A; Atwal H; Forghani I; Atwal PS
    Am J Med Genet A; 2021 Feb; 185(2):539-543. PubMed ID: 33166063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.
    Okur V; Cho MT; Henderson L; Retterer K; Schneider M; Sattler S; Niyazov D; Azage M; Smith S; Picker J; Lincoln S; Tarnopolsky M; Brady L; Bjornsson HT; Applegate C; Dameron A; Willaert R; Baskin B; Juusola J; Chung WK
    Hum Genet; 2016 Jul; 135(7):699-705. PubMed ID: 27048600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity.
    Ernst ME; Baugh EH; Thomas A; Bier L; Lippa N; Stong N; Mulhern MS; Kushary S; Akman CI; Heinzen EL; Yeh R; Bi W; Hanchard NA; Burrage LC; Leduc MS; Chong JSC; Bend R; Lyons MJ; Lee JA; Suwannarat P; Brilstra E; Simon M; Koopmans M; van Binsbergen E; Groepper D; Fleischer J; Nava C; Keren B; Mignot C; Mathieu S; Mancini GMS; Madan-Khetarpal S; Infante EM; Bluvstein J; Seeley A; Bachman K; Klee EW; Schultz-Rogers LE; Hasadsri L; Barnett S; Ellingson MS; Ferber MJ; Narayanan V; Ramsey K; Rauch A; Joset P; Steindl K; Sheehan T; Poduri A; Vasquez A; Ruivenkamp C; White SM; Pais L; Monaghan KG; Goldstein DB; Sands TT; Aggarwal V
    Epilepsia; 2021 Jul; 62(7):e103-e109. PubMed ID: 34041744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo mutations in HNRNPU result in a neurodevelopmental syndrome.
    Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M
    Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Okur-Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion.
    Chiu ATG; Pei SLC; Mak CCY; Leung GKC; Yu MHC; Lee SL; Vreeburg M; Pfundt R; van der Burgt I; Kleefstra T; Frederic TM; Nambot S; Faivre L; Bruel AL; Rossi M; Isidor B; Küry S; Cogne B; Besnard T; Willems M; Reijnders MRF; Chung BHY
    Clin Genet; 2018 Apr; 93(4):880-890. PubMed ID: 29240241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline de novo variants in CSNK2B in Chinese patients with epilepsy.
    Li J; Gao K; Cai S; Liu Y; Wang Y; Huang S; Zha J; Hu W; Yu S; Yang Z; Xie H; Yan H; Wang J; Wu Y; Jiang Y
    Sci Rep; 2019 Nov; 9(1):17909. PubMed ID: 31784560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two different presentations of de novo variants of CSNK2B: two case reports.
    Wilke MVMB; Oliveira BM; Pereira A; Doriqui MJR; Kok F; Souza CFM
    J Med Case Rep; 2022 Jan; 16(1):4. PubMed ID: 34983633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur-Chung neurodevelopmental syndrome.
    Blanc A; Bonnet C; Wandzel M; Roth V; Duffourd Y; Safraou H; Leheup B; Muller F; D Colne J; Feillet F; Schmitt E; Castro M; Savatt J; Burcheri A; Nemos C; Philippe C; Lambert L
    Am J Med Genet A; 2024 Sep; 194(9):e63642. PubMed ID: 38711237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel
    Wu RH; Tang WT; Qiu KY; Li XJ; Tang DX; Meng Z; He ZW
    J Int Med Res; 2021 May; 49(5):3000605211017063. PubMed ID: 34038195
    [No Abstract]   [Full Text] [Related]  

  • 13. [Identification of a novel de novo variant of CSNK2A1 gene in a boy with Okur-Chung neurodevelopmental syndrome].
    Wu R; Tang W; Liang L; Li X; Ouyang N; Meng Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jun; 37(6):641-644. PubMed ID: 32472542
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Yang Q; Zhang Q; Yi S; Qin Z; Shen F; Ou S; Luo J; He S
    Front Neurol; 2022; 13():811092. PubMed ID: 35370893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of Okur-Chung syndrome caused by CSNK2A1 gene variation and review of literature].
    Duan HL; Peng J; Pang N; Chen SM; Xiong J; Guang SQ; Yin F
    Zhonghua Er Ke Za Zhi; 2019 May; 57(5):368-372. PubMed ID: 31060130
    [No Abstract]   [Full Text] [Related]  

  • 16. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
    Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
    Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining of the electroclinical phenotype in familial and sporadic cases of CSNK2B-related Neurodevelopmental Syndrome.
    Trivisano M; Dominicis A; Stregapede F; Quintavalle C; Micalizzi A; Cappelletti S; Dentici ML; Sinibaldi L; Calabrese C; Terracciano A; Vigevano F; Novelli A; Specchio N
    Epilepsy Behav; 2023 Oct; 147():109436. PubMed ID: 37717460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
    Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
    Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [De novo variant of CSNK2B causes Poirier-Bienvenu neurodevelopmental syndrome: two case report].
    Zhang J; Li Y; Luo H; Shen Y; Yuan M; Yang Z; Gan J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):484-487. PubMed ID: 35598262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo missense variants in ZBTB47 are associated with developmental delays, hypotonia, seizures, gait abnormalities, and variable movement abnormalities.
    Ward SK; Wadley A; Tsai CA; Benke PJ; Emrick L; Fisher K; Houck KM; Dai H; ; Guillen Sacoto MJ; Craigen W; Glaser K; Murdock DR; Rohena L; Diderich KEM; Bruggenwirth HT; Lee B; Bacino C; Burrage LC; Rosenfeld JA
    Am J Med Genet A; 2024 Jan; 194(1):17-30. PubMed ID: 37743782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.